Evaluating intermittent androgen-deprivation therapy phase III clinical trials: The devil is in the details

Maha Hussain, Catherine Tangen, Celestia Higano, Nicholas Vogelzang, Ian Thompson

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Evaluating intermittent androgen-deprivation therapy phase III clinical trials: The devil is in the details'. Together they form a unique fingerprint.

Medicine & Life Sciences